key: cord-0695634-td4pw6yd authors: Schiroli, Davide; Merolle, Lucia; Molinari, Giuseppe; Di Bartolomeo, Erminia; Seligardi, Daniela; Canovi, Laura; Pertinhez, Thelma A.; Mancuso, Pamela; Giorgi Rossi, Paolo; Baricchi, Roberto; Marraccini, Chiara title: The impact of COVID‐19 outbreak on the Transfusion Medicine Unit of a Northern Italy Hospital and Cancer Centre date: 2021-06-22 journal: Vox Sang DOI: 10.1111/vox.13174 sha: 0570f8b71ab49bac77575cfbf6a7b4da6f286945 doc_id: 695634 cord_uid: td4pw6yd BACKGROUND AND OBJECTIVES: The first wave of coronavirus disease‐2019 (COVID‐19) dramatically affected the Transfusion Medicine Unit of the Azienda Unità Sanitari Locale ‐ Istituto di Ricovero e Cura a Carattere Scientifico (AUSL‐IRCCS) di Reggio Emilia, which faced a total rearrangement of the procedures for donors and patients. This study aims to assess the major implications of COVID‐19 on our department, focusing on the blood transfusion chain and therapies, in order to support transfusion specialists in seeking efficient ways to face similar future emergencies. MATERIALS AND METHODS: This retrospective study compares our Transfusion Medicine Unit data collected between February and May 2020 with the same period in 2017–2019. Data on red blood cells and platelets donations, transfusions and clinical procedures were collected as aggregates from our internal electronic database. RESULTS: During the lockdown, donor centres were re‐organized to reduce the risk of contagion and avoid unnecessary blood collection. Blood donations were re‐scheduled to meet the decrease in elective surgery; consequently, plateletapheresis was implemented to supply the reduction of buffycoat‐derived platelets. Transfusions significantly decreased together with orthopaedic and vascular surgery, while they were only marginally diminished for both cancer and onco‐haematological patients. Reduced procedures for inpatients and outpatients were matched by remote medicine, addressing the need of a constant healthcare support for patients with chronic diseases. CONCLUSIONS: The described measures were adopted to avoid excessive blood collection and expiration, guarantee the safety of our ward (for both patients and staff) and supply the necessary transfusion therapies. These measures may support the development of appropriate risk management plans and safety procedures for other hospitals and transfusion services that have to face similar events. The first wave of coronavirus disease-2019 (COVID-19) significantly impacted Northern Italy, where hospitals faced a rapid and profound re-organization of the healthcare services supply [1, 2] . The Italian Government declared a lockdown period that, for the Reggio Emilia province, started on 9 March 2020, with a gradual loosening from 3 May 2020 [3] . During this period, all the wards of the AUSL-IRCCS of Reggio Emilia rearranged their routine procedures to meet the requirements imposed by the COVID-19 outbreak. Reggio Emilia hospital is located in Emilia Romagna (Northern Italy) and experienced thousands of COVID-19 cases, with different grades of severity during the lockdown period [4] . The impact of the pandemic on the healthcare system negatively affected a large number of patients with different pathologies [5] [6] [7] [8] [9] . Emilia Romagna Local Governance listed the healthcare services that could not be postponed during the lockdown, as well as those that could be delayed or developed through remote medicine (i.e., telemedicine, electronic prescriptions, phone consultations), in order to limit the access to hospitals and avoid overcrowding [10] . Despite not being involved in first-line treatment of COVID-19 patients, even our Transfusion Medicine Unit faced many changes in its routine clinical practice, due to the close connection with the other hospital departments [11] . To ensure high standards of blood donation and blood safety during the emergency, the Italian National Blood Centre (Centro Nazionale Sangue, CNS), in compliance with the Ministry of Health and the COVID-19 Technical Scientific Committee (CTS), issued a series of measures that our ward promptly adopted [12, 13] . In the present study, we investigate the effects of the COVID-19 pandemic and lockdown-related restrictions on the activity of our Transfusion Medicine Unit, providing a description of the adopted measures and of their effectiveness on blood collection, blood transfusions, transfusion medicine and immune-haematology clinical practice. Our aim is to point out, through an evidence-based analysis, the practices that may help transfusion specialists worldwide to deal with similar emergencies in the future. Reggio Emilia is one of the nine provinces located in the Emilia-Romagna region, accounting for about 532,000 inhabitants. The Emilia-Romagna region coordinates blood availability and distribution between the provinces via the Regional Blood Centre (Centro Regionale Sangue [CRS]). Reggio Emilia province harbours five hospitals. Nevertheless, there is only a Transfusion Medicine Unit that centralizes the necessity for transfusions, therapies and medical consultations. The study was carried out at the Transfusion Medicine Unit of the Azienda USL-IRCCS di Reggio Emilia. This is a retrospective study comparing data from February to May 2020 with the same period of the previous triennium (2017-2019). Since one-way analysis of variance (ANOVA) analysis did not reveal significant difference (p > 0.05) in the mean transfusions among the tested groups (2017-2019), total red blood cells (RBCs) transfusions performed during the 2020 lockdown were compared with the mean transfusions performed during the same period of the previous triennium. During the national lockdown period, Reggio Emilia donor centres were re-organized to: 1. Lower the risk of contagion. To lower the risk of contagion, two small donor centres were temporarily closed and converted into COVID clinics. In the remaining operating centres, some of the personnel were appointed to check the temperature and health status of all donors immediately before their access. Social distancing measures were adopted to avoid overcrowding, and, after each donation, rooms and seats were sanitized. Donations were suspended for students and first donors; when not necessary, eligibility and control exams were halted. Blood, PLTs and plasma donations are routinely planned with the donors by SMS alert or phone call and scheduled in order to adequately manage the blood bank. During the 2020 lockdown, the schedule was deeply modified to meet the hospital requirements. According to the Italian Government instructions [3] , our hospital re-scheduled a large majority of surgical procedures. When possible, non-urgent orthopaedics, cardiovascular and cancer surgeries were postponed or moved to non-COVID hospitals. This had an impact on the total number of surgical interventions, especially during the most critical lockdown phase (i.e., March and April 2020, data not shown). As a consequence, the Transfusion Medicine Unit faced a decrease in blood components' requests, and blood donation schedules were all re-considered in order to avoid excessive stored blood units. Plateletapheresis was, thus, increased to allow a constant PLTs supply to our blood bank (Figure 1(b) ). Whole blood donations dedicated to group 0 negative (0À) (Supplementary Figure S1 ) and rare phenotypes reserved for specific cohorts of patients (i.e., thalassaemics and myelodysplastics) were preserved. Rare group donors were scheduled by direct phone call, while all the other appointments were cancelled by SMS. Since plateletapheresis is a complex and invasive procedure, PLTs donors are generally fewer than blood donors. The collection of a sufficient amount of plateletapheresis-derived units, therefore, represented a challenge for our recruiting personnel. To overcome this problem, our Transfusion Medicine Unit established a bank of frozen PLTs, which can be stored for up to 2 years. Between August and October 2020, our personnel collected and stored over 50 frozen PLTs units, according to Italian standards [14] . To understand how the pandemic affected the transfusion therapies, we compared the percentages of hospitalized patients transfused between February and May 2020 with those of 2017-2019 (Table 1) In parallel, we investigated PLTs transfusions, we observed a slight decrease in patients and units transfused during the lockdown (Figure 3(a) ), although only these last data are significant (p < 0.01). PLTs transfusions started decreasing 3 weeks after the beginning of lockdown and came back to the 2019 level within 1 month. The largest amount of PLTs units transfused during the second month of lockdown (i.e., April 2020) came from plateletapheresis, as a consequence of the reduction of buffycoat-derived pools following the decrease of whole blood donations (Figure 3(b) ). As mentioned earlier, the establishment of the CORE pavilion implied an increase of hospitalized onco-haematological patients between 2017 and 2019. Therefore, the effects of the lockdown on transfusion therapies for this sub-group of patients are described in comparison with 2019 only. RBCs account for about 20% of the total, and their caregiving was preserved as much as possible during the first wave of the pandemic. Nevertheless, during the lockdown, we also observed a slight decrease of RBCs transfusions for these patients (Figure 4(a) ). Although these data were not highly significant, it is supported by a similar observation on PLTs transfusions (Figure 4(b) ). Following the official resolution of the Emilia-Romagna region [14] , our Transfusion Medicine Unit totally re-organized its services to: • Limit the access of patients to emergencies and unavoidable therapies; • Guarantee transfusions and other therapies to patients coming from other wards; Procedures on outpatients decreased as well, particularly iron infusions on anaemic pre-operative patients ( Figure 5(b) ). Between April and May, our physicians started implementing medical phone consultations for the outpatients (Figure 5(c) ). The Patient Blood Management medical office, which routinely performs medical consultations to pre-operative patients, temporarily closed due to the lack of elective surgeries imposed by the lockdown. The treatment of chronically ill patients (thalassaemic, polycythaemic, familial hypercholesterolaemia patients among all) was preserved as much as possible, albeit the patients' appointments were spread over a longer range of time (from 8 AM-12 noon to 8 AM-6 PM). All patients were only allowed to stay for the exact time of the hospital procedure. Visitors were not allowed, except when accompanying minors or fragile patients. When possible, on-site appointments were substituted by remote consultations. Although not shown in this study, medical assistance by phone was implemented during the whole summer in order to be prepared for a second pandemic wave. Between March and May 2020, the Italian Government declared a national lockdown, accompanied by further regional indications on the management of healthcare services that significantly changed the routine and emergency procedures all over the country [3, 10, 15] . The COVID-19 outbreak also severely affected the procedures of the AUSL-IRCCS di Reggio Emilia: the number of non-COVID patients accessing the hospital between February and May 2020 was only 10,520, which is over 33% less than the same period of the previous triennium (15,771). In accordance with what was previously reported, in our hospital, only a few hospitalized COVID-19 patients might have received a blood transfusion as a consequence of the pathology (161 over 1720, 9.4%) [16] . In terms of organization, the main changes for our Transfusion Medicine Unit involved blood donations, which were significantly reduced and re-scheduled to meet the decrease need of blood components, as similarly described in other blood centres [17] [18] [19] . To After the initial reduction of the routine procedures, the healthcare supply for cancer and onco-haematological patients was gradually restored following the national and regional indications [10, 15, 20] . Accordingly, a decrease in blood transfusions for the onco-haematological patients was mainly concentrated in the most critical weeks (between the 20th of March and the 5th of April, Figure 4 ), while PLTs transfusion (mainly administered to prevent or treat bleeding episodes of onco-haematological patients) remained constant for the whole lockdown duration. To compensate for the decrease in buffycoat-derived PLTs units, we increased the number of PLTs donations (Figure 2(c) ). The latter are not easily collected in an adequate quantity to satisfy the request, and we thus adopted a procedure to store frozen PLTs [21] . PLTs cryopreservation is an alternative to the conventional storage temperature (25 C) that allows the product shelf-life to increase from 5 days to up to 2 years. Following the decrease of inpatients hospitalized by other wards, our physicians faced a significant decrease of medical consultations ( Figure 5(a) ) and plasma-exchange procedures. In summary, the COVID-19 pandemic deeply impacted the healthcare systems at all levels, with important implications also for blood donation and transfusion [12, 22] . The mechanisms and procedures adopted to face this serious emergency were necessary to meet the safety requirements for donors, patients and staff. Our experience has, actually, many points in common with other Transfusion Medicine Units in Italy and other parts of the world [11, 12, 23, 24] . Among the strategies developed to meet this health emergency, we believe that, alongside the consolidated practices such as sanitizing procedures, re-modulation of access and the use of personal protective equipment [25] , a provision of frozen blood components that can be stored for several months could be helpful during emergency periods and should be promptly planned. Moreover, remote appointments were revealed as effective, especially for chronically ill patients, and it has been implemented after the lockdown. Although our data are in agreement with recent literature about transfusion in COVID-19 patients, [16] we must point out that they come from our internal database, which is not directly connected to clinical records and other hospital databases. Therefore, it is plausible that some data are underestimated, especially those relating to cancer patients (other than onco-haematological). The latter can be hospitalized by several wards in our hospital, depending on tumour localization, and this implies higher tracing complexity; furthermore, when a physician prescribes a blood component, the diagnosis can sometimes not be well specified, thus generating missing data in our internal database. Nevertheless, our electronic system blocks blood component requirements in case of missing diagnosis, and we are confident that, despite a slight underestimation, the data presented herein are close to reality. Finally, between February and May 2020, a 'COVID-19 diagnosis' was not present in our database. Therefore, we cannot discriminate between RBCs and PLTs units transfused for COVID-19 or for medical/surgical reasons. Nevertheless, we traced the requests for transfusions coming from the wards that hosted COVID-19 patients, and we did not find any significant variation (data not shown). In conclusion, during the first wave of the pandemic, our Transfusion Medicine Unit both avoided unnecessary blood collection and excessive stored blood units, preserving donor and staff safety. This result was reached by coordinating with the internal (hospital wards and donor centres) and external (i.e, CRS) stakeholders. However, these measures come from an emergency phase, and, despite their effectiveness, they should be implemented with other strategies (such as prioritizing blood use for hospitalized patients during blood shortage events) and integrated in appropriate risk management plans and safety procedures. At the time of writing, the spread of COVID-19 is still beyond control in many countries worldwide; the knowledge acquired during the emergency should not be dispersed, but exploited, in order to define a more efficient healthcare management. COVID-19: update of the Italian situation Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy Disposizioni urgenti per il potenziamento del Servizio sanitario nazionale in relazione all'emergenza COVID-19. Decreto del Presidente del Consiglio dei Ministri 9 Marzo 2020: 23 febbraio 2020, n. 6, recante misure urgenti in materia di contenimento e gestione dell'emergenza epidemiologica da COVID-19, applicabili sull Characteristics and outcomes of a cohort of COVID-19 patients in the province of Reggio Emilia Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy Delayed access or provision of care in Italy resulting from fear of COVID-19 The orthopaedic and traumatology scenario during Covid-19 outbreak in Italy: chronicles of a silent war Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective Facing Covid-19 in Italy -ethics, logistics, and therapeutics on the epidemic's front line Salute e Welfare Regione Emilia Romagna Effects of the COVID-19 pandemic on supply and use of blood for transfusion The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy Patient blood management during the COVID-19 pandemic: a narrative review Blood transfusion utilization in hospitalized COVID-19 patients Impact of the COVID-19 -a regional blood center's perspective Impact of COVID-19 on blood centres in Zhejiang Province China Blood supply management in times of SARS-CoV-2 pandemic -challenges, strategies adopted, and the lessons learned from the experience of a hospital-based blood Centre Disposizioni attuative del decreto-legge 23 febbraio 2020, n. 6, recante misure urgenti in materia di contenimento e gestione dell'emergenza epidemiologica da COVID-19 A simple method for freezing human platelets using 6% dimethylsulfoxide and storage at-80 C Vox Sanguinis international forum on transfusion services' response to COVID-19: summary Tools for rapid analysis of blood usage and inventory during the COVID-19 pandemic Impact of COVID-19 pandemic in the activity of a therapeutic apheresis unit in Italy A multimodal practical approach in a transfusion medicine Centre to face the COVID-19 outbreak The authors wish to thank all the staff, donors and blood associations volunteers who demonstrated their commitment to patients care during this serious health emergency. The authors declare no conflict of interest.